To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GTCR to sell stem cell company to AMAG for $700m
The private equity firm initially invested in Cord Blood Registry in 2012 through its Fund X
